Merck KGaA Doubles Down On Life Sciences With $11.3bn Bio-Techne Buyout Scrip Pharma Intelligence 20h
Stock Market Today, June 25: Bio-Techne Surges After Merck KGaA Announces $73-Per-Share Cash Acquisition Offer The Motley Fool 2d
Bio-Techne Corp Stock Gains 19% Over $11.3 Bln Acquisition Deal From Germany's Merck KGaA RTT News 2d
Germany’s Merck pumps up life sciences biz with $11.3B Bio-Techne deal Power Corridor 1d Merck KGaA Bio-Techne Pharma All sources
Merck to acquire Bio-Techne for $11.3bn, expanding bioprocessing and cell therapy capabilities Manufacturing Chemist 1d Mergers and Acquisitions Pharma Biotechnology
Merck Foundation, 12 African/Asia first ladies vow to improve healthcare delivery, capacity building ThisDay Live 7d Merck Foundation Pharma All sources
Pfizer announces phase 3 results for potential non-small cell lung cancer treatment PMLiVE 1d Lung Cancer Pfizer Cancer
